Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Dr. Reddy's Lab history
Dr. Reddy's Lab company history timeline
In 1984, he decided to strike out on his own and established Doctor Reddy's Laboratories and acquired Cheminor Drugs an existing bulk drug manufacturing company.
By 1986, the company prepared to expand still further, and listed its stock on the Bombay exchange.
The company achieved another crucial milestone in 1987 when it gained United States FDA approval for its ibuprofen formulation.
1988: The company acquires Benzex Laboratories in order to expand the bulk actives business.
International sales were also becoming an increasingly important part of the company's total revenues, a trend boosted by the company's entry into the Russian market in 1991.
By 1993, the company's new research and development wing was operational, and it set to work performing "drug discovery" work in a variety of fields, including metabolic disorders, such as diabetes, and cancer treatments, among others.
1994: The company opens a subsidiary in the United States.
The company successfully completed laboratory testing on the drug, an insulin sensitizer dubbed balaglitazone by 1997.
The year 1997 marked a new era for Doctor Reddy's.
2000: The company acquires Cheminor Drugs Limited and becomes the third largest Indian drug company.
The year 2002 also marked the company's first overseas acquisition, when it paid £9 million to acquire the United Kingdom's BMS Laboratories Ltd. and its marketing and distribution subsidiary Meridian Healthcare Ltd.
The company then began preparations to introduce its version of the drug in 2003.
2003: The company gains tentative approval to market generic versions of Serzone, developed by Bristol Myers Squibb.
Details of Shares for transfer to IEPF May 2018
Details of Shares for transfer to IEPF May 2019
Details of Shares for transfer to IEPF May 2020
Details of Shares for transfer to IEPF May 2021
© 2021 Doctor Reddy’s Laboratories Ltd.
Rate Dr. Reddy's Lab's efforts to communicate its history to employees.
Dr. Reddy's Lab jobs
Do you work at Dr. Reddy's Lab?
Does Dr. Reddy's Lab communicate its history to new hires?
Dr. Reddy's Lab competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Sentynl Therapeutics | 2014 | $50.0M | 23 | - |
| Ash Stevens | 1962 | $18.4M | 69 | - |
| DUSA Pharmaceuticals | 1991 | $45.3M | 50 | - |
| Clinical Data | 2007 | - | 160 | - |
| Cytel | 1987 | $49.9M | 1,000 | 310 |
| Zydus Pharmaceuticals | 2005 | $500.0M | 179 | 6 |
| Ranbaxy Pharmaceuticals Inc | 2004 | $680.0M | 1,000 | - |
| Medivation | 2003 | $1.0B | 628 | - |
| Biocon | 2003 | $590.0M | 9,234 | 1 |
| Incyte | 1991 | $4.2B | 1,600 | 37 |
Dr. Reddy's Lab history FAQs
Zippia gives an in-depth look into the details of Dr. Reddy's Lab, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dr. Reddy's Lab. The employee data is based on information from people who have self-reported their past or current employments at Dr. Reddy's Lab. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dr. Reddy's Lab. The data presented on this page does not represent the view of Dr. Reddy's Lab and its employees or that of Zippia.
Dr. Reddy's Lab may also be known as or be related to Dr Reddy s Laboratories Inc, Dr Reddy's Laboratories, Dr Reddy's Laboratories Inc and Dr. Reddy's Lab.